Pedigree in Lifestyle

The thing that sets India's second-largest MNC pharma company, GSK Pharma, apart from the others is the patents owned by parent company GSK Plc. GSK Plc continues to launch most of its patented products, like in the past, through its listed Indian entity. This association has paid GSK Pharma rich dividends. GSK's phenomenal 47 per cent (average) ROCE in the last five years is one of the highest in the industry (current RoCE at 47.8 per cent). GSK's PAT margins have averaged 25 per cent in the same period - again a feat that few pharma companies can match up with. Strengths and Opportunities A fine pedigree. GSK Pharma has a strong presence in high growth lifestyle segments of dermatology, respiratory and vaccines. Its parent company holds one of the l

This article was originally published on September 13, 2012.